Inscription à l’infolettre

Publications

Publications récentes

Voir les publications précédentes
  • 1er janvier 2023

    Defining the elusive oncogenic role of the methyltransferase TMT1B.

    Denford SE, Wilhelm B
    Front Oncol 2023-01-01 ;13:1211540

  • 1er janvier 2023

    Klf4 protects thymus integrity during late pregnancy.

    Depoërs L, Dumont-Lagacé M, Trinh VQ, Houques C, Côté C, Larouche JD, Brochu S, Perreault C
    Front Immunol 2023-01-01 ;14:1016378

  • 1er janvier 2023

    Profiling the Epigenetic Landscape of the Tumor Microenvironment Using Chromatin Immunoprecipitation Sequencing.

    Fukano M, Alzial G, Lambert R, Deblois G
    Methods Mol Biol 2023-01-01 ;2614:313-348

  • 1er janvier 2023

    The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.

    Vallet A, El Ezzy M, Diennet M, Haidar S, Bouvier M, Mader S
    J Biol Chem 2023-01-01 ;299( 1 ):102757

  • 1er janvier 2023

    Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD.

    Claveau JS, LeBlanc R, Ahmad I, Delisle JS, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J
    Transplant Cell Ther 2023-01-01 ;29( 1 ):44.e1-44.e9

  • 1er janvier 2023

    Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

    Lachance S, Bourguignon A, Boisjoly JA, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Veilleux O, Zehr J, Chagnon M, Roy J
    Transplant Cell Ther 2023-01-01 ;29( 1 ):34.e1-34.e7

  • 1er janvier 2023

    Silicone particles in capsules around breast implants: Establishment of a new pathological methodology to assess the number of particles around breast implants.

    Dziubek M, Laurent R, Bonapace-Potvin M, Gaboury L, Danino MA
    Ann Chir Plast Esthet 2023-01-01 ;68( 1 ):19-25

  • 1er janvier 2023

    Combined IFN-γ and JAK inhibition to treat hemophagocytic lymphohistiocytosis in mice.

    Joly JA, Vallée A, Bourdin B, Bourbonnais S, Patey N, Gaboury L, Théorêt Y, Decaluwe H
    J Allergy Clin Immunol 2023-01-01 ;151( 1 ):247-259.e7

Voir plus de publications